Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) is one of the Best Non-Mega Cap NASDAQ Stocks to Buy Right Now. UBS analyst Trung Huynh raised the price target on Regeneron Pharmaceuticals, Inc.

Masai Ujiri’s unexpected departure from the Toronto Raptors front office came as a surprise to many around the league. Over his tenure, Ujiri cemented his reputation as one of the NBA’s top ...

26 analysts have shared their evaluations of Regeneron Pharmaceuticals REGN during the recent three months, expressing a mix of bullish and bearish perspectives. In the table below, you'll find a ...

A seven-day trial commenced on May 5, 2025. 21 During trial, Dr. Leonard Schleifer, Founder, CEO, and President of Regeneron, testified that after ESI received Amgen’s offer, ESI told Dr ...

Bispecific antibodies are already available for treating multiple myeloma. FDA approval of Regeneron Pharmaceuticals’ new drug, Lynozyfic, comes with dosing flexibility that sets it apart from ...

Another BCMA-targeted agent has arrived for the treatment of multiple myeloma. | After a delay, Regeneron’s BCMA-directed bispecific antibody Lynozyfic has won an FDA approval with a more ...

It may be a year later than originally planned, but Regeneron Pharmaceuticals Inc. is set to commercialize Lynozyfic (linvoseltamab) in the U.S. following FDA approval for use in adults with relapsed ...

Leonard played the 2024-25 season while on a minor-league deal with AHL Charlotte, racking up 36 goals and 25 assists in 72 regular-season games for the Checkers.

Kawhi Leonard Debuts His Own New Balance 480 V2s Three Kawhi Leonard-designed 480 V2 colorways are dropping in 2026.